Profusa Reports Worsening Q1 Losses, Cash Burn; Faces Conditional Nasdaq Listing and Highly Dilutive Financing Amidst Going Concern Doubt

summarizeSummary

Profusa, Inc. reported a significant deterioration in Q1 2026 financials with increased losses and cash burn, alongside an explicit going concern warning and ongoing Nasdaq delisting threats, despite a conditional reprieve. The company also engaged in highly dilutive financing and announced a large, conditional acquisition.

check_boxKey Events

• Severe Financial Deterioration

  Net loss increased 27% to $3.5 million, and cash used in operations surged 380% to $2.6 million in Q1 2026 compared to Q1 2025. Cash on hand dropped to $0.4 million by March 31, 2026, from $1.8 million at year-end 2025, with a working capital deficit of approximately $28.4 million.

• Ongoing Going Concern Doubt

  Management explicitly states substantial doubt about the company's ability to continue as a going concern within the next year, despite recent financing efforts.

• Conditional Nasdaq Listing Reprieve

  The company received a conditional reprieve from Nasdaq on May 6, 2026, requiring a transfer to the Nasdaq Capital Market (effective May 15, 2026), stockholder approval for another reverse stock split by June 5, 2026, and compliance with minimum bid price and stockholders' equity by July 6, 2026.

• Highly Dilutive Financing and Conditional Acquisition

  Subsequent to quarter-end, Profusa issued $1.7 million in new 12% convertible PIPE notes and warrants for 3.33 million shares at a $0.50 exercise price. It also converted $1.9 million of related party debt into 2.46 million shares at $0.76/share and entered a definitive agreement to acquire PanOmics Assay for $30 million in convertible preferred stock, subject to shareholder approval.

auto_awesomeAnalysis

The Q1 2026 results confirm and worsen Profusa's severe financial distress, with escalating losses and a rapid depletion of cash. The explicit going concern warning underscores the precarious situation. While a conditional Nasdaq listing reprieve offers a temporary lifeline, the requirement for another reverse stock split and equity compliance highlights the persistent challenges. The subsequent dilutive financing and the large, conditional acquisition, payable in convertible preferred stock, introduce substantial future dilution and execution risk for a company already struggling for survival. Unremediated material weaknesses in financial reporting further erode investor confidence.